Among patients with MNV type 2, SHRM showed a decreasing trend over the 5-year follow-up, although the reduction was not statistically significant.
← all excerpts
Neovascular Age-Related Macular Degeneration Treated with Aflibercept: Five-Year Follow-Up and Correlation with Optical Coherence Tomography Biomarkers in a Real-World Setting.
1
—
—